Connect with us

Company News

Inspira™ announces USD 1.65M registered direct offering of ordinary shares

Inspira Technologies OXY B.H.N. Ltd. announced a strategic investment by leading investor, Ronen Juster, and the mother of Inspira’s Chief Executive Officer, Ms. Margi Ben-Noon. The Company has entered into a definitive agreement for the issuance and sale of an aggregate of 1,339,285 of ordinary shares at a price per share of $1.232, in a registered direct offering. The offering is expected to close on or about April 2, 2024, subject to the satisfaction of customary closing conditions.

The proceeds to Inspira from the offering are expected to be $1.65 million Inspira currently intends to use the net proceeds from the offering for working capital and general corporate purposes.

The securities described above are being offered and sold by the Company in a registered direct offering pursuant to a “shelf” registration statement on Form F-3 (Registration No. 333-266748), including a base prospectus, previously filed with the Securities and Exchange Commission (SEC) on August 10, 2022, and declared effective by the SEC on August 18, 2022. The offering of such securities is being made only by means of a prospectus supplement that forms a part of the registration statement.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!